Loading…
Seaport Therapeutics, Inc. is projected to rise to $30.41 by 2027, a +49% move from its current price of $20.46. SPTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $19.65 | $20.47 | $21.31 | +0.03% |
| Aug 3 | $19.33 | $20.47 | $21.68 | +0.06% |
| Aug 4 | $19.09 | $20.48 | $21.97 | +0.09% |
| Aug 5 | $18.89 | $20.48 | $22.22 | +0.12% |
| Aug 6 | $18.71 | $20.49 | $22.44 | +0.15% |
| Aug 7 | $18.56 | $20.50 | $22.64 | +0.18% |
| Aug 8 | $18.42 | $20.50 | $22.83 | +0.21% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $18.42 | $20.50 | $22.83 | +0.21% |
| Week 2 | $17.65 | $20.55 | $23.91 | +0.42% |
| Week 3 | $17.10 | $20.59 | $24.80 | +0.64% |
| Week 4 | $16.65 | $20.63 | $25.57 | +0.85% |
| Week 5 | $16.27 | $20.68 | $26.29 | +1.06% |
| Week 6 | $15.93 | $20.72 | $26.95 | +1.28% |
| Week 7 | $15.63 | $20.77 | $27.58 | +1.49% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Seaport Therapeutics, Inc. is a clinical-stage healthcare company focused on developing medicines for depression, anxiety, and other debilitating neuropsychiatric disorders. It leverages its proprietary Glyph platform to advance a pipeline of therapies to address the unmet needs in depression and anxiety.
Its lead product candidate is GlyphAllo (SPT-300 or Glyph Allopregnanolone), a novel, Glyphed oral prodrug of allopregnanolone, and its second program GlyphAgo (SPT-320 or Glyph Agomelatine) is a novel, Glyphed oral prodrug of agomelatine. The company was founded in 2024 and is based in Boston, Massachusetts.
Seaport Therapeutics, Inc. trades at $21.00 and has a market cap of $1.12B. It ranks 2449 in market position. The long-range outlook shows a rising price path across the forecast years, with averages increasing from $21.00 in 2026 to higher levels by 2050.
The trajectory includes notable multipliers in the later years, with projected averages such as $49.82 in 2030, $125.73 in 2040, and $305.02 in 2050, implying meaningful upside under the provided assumptions.
A major floor 25.5% below — a decisive break under it would weaken the trend.
The nearest floor, 12.1% below — buyers have tended to step in here.
The nearest ceiling, 10.1% above — a clean break opens room to run.
A major ceiling 21.5% above — clearing it would confirm fresh momentum.
Key SPTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SPTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $20.19 | Buy | $20.37 | Buy |
| MA 10 | $20.68 | Sell | $20.47 | Sell |
| MA 20 | $20.46 | Buy | $20.35 | Buy |
| MA 50 | $19.18 | Buy | $19.67 | Buy |
| MA 100 | — | Neutral | — | Neutral |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.34 | Neutral |
| Stoch RSI (14) | 34.16 | Neutral |
| CCI (20) | 0.22 | Neutral |
| Williams %R (14) | -61.16 | Info |
| MACD (12,26,9) | -0.16 | Sell |
| ROC (12) | 0.05 | Buy |
| Bollinger %B (20,2) | 0.50 | Neutral |
| Stochastic %K (14) | 38.84 | Neutral |
| TRIX (15) | 0.36 | Buy |
| Awesome (5,34) | 0.16 | Buy |
| Ultimate (7,14,28) | 44.76 | Neutral |
| Momentum (10) | -0.39 | Sell |
| Aroon Osc (25) | -20.00 | Sell |
| Hull MA (9) | 19.80 | Buy |
| ADX (14) | 8.96 | Neutral |
| ATR (14) | 0.67 | Info |
The near-term technical picture is labeled bullish. The RSI(14) is 50, indicating a balanced momentum near the threshold between bullish and bearish. The 50-day simple moving average sits at $18.46, providing a reference level for near-term trend dynamics.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $15.25 | $20.46 | $31.84 | 0% | Neutral | |
| $21.55 | $30.41 | $46.51 | +49% | Bullish | |
| $25.69 | $38.98 | $64.02 | +91% | Bullish | |
| $24.08 | $38.89 | $67.40 | +90% | Bullish | |
| $25.13 | $42.97 | $77.86 | +110% | Bullish | |
| $26.40 | $47.63 | $89.63 | +133% | Bullish | |
| $23.31 | $44.29 | $86.17 | +116% | Bullish | |
| $27.23 | $54.41 | $109.06 | +166% | Bullish | |
| $34.35 | $72.11 | $148.52 | +252% | Bullish | |
| $36.33 | $80.08 | $169.09 | +291% | Bullish | |
| $45.08 | $100.17 | $230.39 | +390% | Bullish | |
| $105.60 | $234.66 | $539.73 | +10.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $15.25 | $20.46 | $25.64 | +0.00% |
| September 2026 | $16.24 | $19.94 | $25.64 | -2.56% |
| October 2026 | $16.87 | $21.03 | $27.66 | +5.50% |
| November 2026 | $18.13 | $22.91 | $30.67 | +8.91% |
| December 2026 | $18.31 | $23.40 | $31.84 | +2.16% |
Click any year to see its month-by-month SPTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect SPTX to range from $15.25 to $31.84 through 2026. The $20.46 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The SPTX price prediction for 2027 points to an average of $30.41 (low $21.55, high $46.51) — a potential gain of +49% on today's $20.46. Buyers look set to stay in control over this stretch.
In 2028, SPTX is projected to trade between $25.69 and $64.02, averaging $38.98 — a potential gain of +91% from today's $20.46. That is up +28% on the projected 2027 average. Momentum favours further upside here.
Seaport Therapeutics, Inc.'s 2029 outlook centres on $38.89, within a $24.08 to $67.40 range. That is 0% versus the projected 2028 average. That marks a +90% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, SPTX could reach as high as $77.86, with a base case around $42.97 and support toward $25.13 — roughly +110% from $20.46. Momentum favours further upside here.
Expect SPTX to range from $26.40 to $89.63 through 2031. The $47.63 average target implies a +133% move from current prices. That is up +11% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The SPTX price prediction for 2032 points to an average of $44.29 (low $23.31, high $86.17) — a potential gain of +116% on today's $20.46. Momentum favours further upside here.
In 2033, SPTX is projected to trade between $27.23 and $109.06, averaging $54.41 — a potential gain of +166% from today's $20.46. That is up +23% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Seaport Therapeutics, Inc.'s 2034 outlook centres on $72.11, within a $34.35 to $148.52 range. That is up +33% on the projected 2033 average. That marks a +252% change versus current levels. Momentum favours further upside here.
By 2035, SPTX could reach as high as $169.09, with a base case around $80.08 and support toward $36.33 — roughly +291% from $20.46. Buyers look set to stay in control over this stretch.
Expect SPTX to range from $45.08 to $230.39 through 2040. The $100.17 average target implies a +390% move from current prices. That is up +25% on the projected 2035 average. Momentum favours further upside here.
The SPTX price prediction for 2050 points to an average of $234.66 (low $105.60, high $539.73) — a potential gain of +10.5x on today's $20.46. Buyers look set to stay in control over this stretch.
Investing $1,000 in SPTX today (≈ 48.875855 SPTX) could be worth
$11,469.43
+$10,469.43 (+1047%) by 2050 · US Dollar
Based on the average projected SPTX price of $234.66 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SPTXwould be worth at today's price.
$1,000 invested in SPTX on May 1, 2026 (≈ 50.403225 SPTX) would be worth
$1,031.25
+$31.25 (+3.1%) today · 1.03× · US Dollar
Based on a SPTX entry price of $19.84 vs. today's $20.46.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $21.1 | $969.67 | -3.0% |
| 1 month ago | $21.45 | $953.85 | -4.6% |
| 3 months ago | $19.84 | $1,031.25 | +3.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SPTX forecast.
Our base-case forecast reaches $41.00 around 2030.
Implied market cap at $41.00: $2.19B
The multi-year forecast shows a continuing bullish bias across the horizon, with the average price rising across key milestones. In 2030, the average is $49.82 with a bullish sentiment and an implied return of 137.2% from the base 2026 level. By 2040, the average climbs to $125.73 with an implied ROI of 498.7%, sustaining a bullish outlook through 2050 where the average reaches $305.02 and the ROI expands to 1352.5%.
The sequence reflects strong upside potential but carries the caveat of notable volatility, as shown by the 90% annualized volatility level in the near term. These are projections, not guarantees, and outcomes depend on numerous factors.
Tap a question to reveal the answer.
2030: avg $49.82; min $25.88; max $97.70; ROI 137.2%; sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward with rising averages; 2026 is Neutral with avg $21.00 and ROI 0%. From 2027 to 2050, the outlook remains bullish with progressively higher averages and ROIs (e.g., 63.7% in 2027 up to 1352.5% in 2050).
2030 max is $97.70, so it does not reach $100 by 2030 according to the forecast.
Current price is $21.00 and market cap is $1.12B.
2040: avg $125.73; min $56.58; max $289.18; ROI 498.7%; sentiment BULLISH.
Seaport Therapeutics, Inc. Community Discussion
0Share your Seaport Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.